menu search

Reviva pharmaceuticals: positive results in phase 3 but the stock is back where it started

Results from the phase 3 RECOVER study of Reviva pharmaceuticals' antipsychotic brilaroxazine in schizo...

November 2, 2023, 3:11 am

Corvus pharmaceuticals announces publication of preclinical data demonstrating potential of itk inhibition with soquelitinib as a novel approach to t cell-mediated inflammatory and immune diseases

Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides rationale for development in a range of additional Th...

November 1, 2023, 11:31 pm

Tarsus to report third quarter 2023 financial results on thursday, november 9, 2023

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Tarsus pharmaceuticals, Inc. (NASDAQ: TARS), whose m...

November 1, 2023, 10:35 pm

Olema oncology to participate in upcoming investor conferences in november

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Olema pharmaceuticals, Inc. (“Olema”, “Olema On...

November 1, 2023, 8:27 pm

Biomarin pharmaceutical, inc. (bmrn) q3 2023 earnings call transcript

Biomarin pharmaceutical, Inc. (NASDAQ:BMRN ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ...

November 1, 2023, 7:36 pm

Ligand pharmaceuticals (lgnd) laps the stock market: here's why

In the most recent trading session, Ligand pharmaceuticals (LGND) closed at $53.30, indicating a +1.93%...

November 1, 2023, 7:32 pm

Ani pharmaceuticals (anip) stock drops despite market gains: important facts to note

ANI pharmaceuticals (ANIP) closed at $61.66 in the latest trading session, marking a -0.13% move from t...

November 1, 2023, 7:32 pm

Tarsus to report third quarter 2023 financial results on thursday, november 9, 2023

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tarsus pharmaceuticals, Inc. (NASDAQ: TARS), whose mi...

November 1, 2023, 6:35 pm

Avicanna to hold third quarter 2023 earnings conference call

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a bio...

November 1, 2023, 5:55 pm

Hillevax to present at upcoming investor conferences

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical...

November 1, 2023, 4:48 pm

Olema oncology to participate in upcoming investor conferences in november

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema pharmaceuticals, Inc. (“Olema”, “Olema Onc...

November 1, 2023, 4:27 pm

Amphastar pharmaceuticals to release third quarter earnings and hold conference call on november 8, 2023

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar pharmaceuticals, Inc. (NASDAQ:AMPH) an...

November 1, 2023, 4:10 pm

Xenon pharmaceuticals announces conference call and webcast to discuss third quarter 2023 financial results and provide corporate update

VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Xenon pharmaceuticals Inc. (Nasdaq:XENE)...

November 1, 2023, 4:01 pm

Gracell biotechnologies to participate in four upcoming investor conferences

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDA...

November 1, 2023, 4:00 pm

Apellis pharmaceuticals, inc. (apls) q3 2023 earnings call transcript

Apellis pharmaceuticals, Inc. (NASDAQ:APLS ) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ...

November 1, 2023, 2:36 pm

Processa pharmaceuticals announces formation of oncology advisory board with renowned key opinion leaders

Company To Leverage World-Class Oncology Advisory Board in the Design of Oncology Trial Protocols, Including the Anticipated Phase 2 Trial for NGC-Cap...

November 1, 2023, 12:15 pm

Mgc pharmaceuticals clarifies share consolidation and new fundraise

MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has provided clarity on the company's consolidati...

November 1, 2023, 11:37 am

Masonic cancer center, university of minnesota to present data in poster presentation human data readout for phase 1 study to evaluate hcw9218 in solid tumors at sitc 38th annual meeting

HCW9218 is the lead product candidate of HCW Biologics Inc. MIRAMAR, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or...

November 1, 2023, 11:30 am

Biopharmaceutical stock soars on earnings beat

TG Therapeutics Inc (NASDAQ:TGTX) stock is soaring today, after the biopharmaceutical name's third-quar...

November 1, 2023, 11:29 am

Is medpace (medp) outperforming other medical stocks this year?

Here is how Medpace (MEDP) and Acadia pharmaceuticals (ACAD) have performed compared to their sector so...

November 1, 2023, 11:21 am


Search within

Pages Search Results: